Results 121 to 130 of about 699,670 (339)
Disability weights for comorbidity and their influence on Health-adjusted Life Expectancy
Population Health Metrics, 2006 Background Comorbidity complicates estimations of health-adjusted life expectancy (HALE) using disease prevalences and disability weights from Burden of Disease studies.
de Wit G Ardine +4 more
doaj +1 more source
Longterm Outcome Following Stroke-Dependency, Comorbidity and Residence [PDF]
, 1990 G Greveson +3 more
openalex +1 more source
Arthritis Care &Research, Accepted Article.Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim +18 more
wiley +1 more source
ASSESSMENT OF COMORBIDITY IN THOSE SUFFERING FROM CHRONIC OBSTRUCTIVE PULMONARY D
Туберкулез и болезни лёгких, 2017 Goal of study: to assess the Charlson comorbidity index in those suffering from chronic obstructive pulmonary disease (COPD).Materials and methods. 207 patients suffering from COPD smoking for a long period of time (the smoker index of 240 and time of ...
E. V. Kochetova
doaj +1 more source
Examining the health-related quality of life of people with end-stage kidney disease living in Hanoi, Vietnam [PDF]
, 2012 Background: The prevalence of end-stage kidney disease (ESKD) patients is increasing in Vietnam; however, the impact of ESKD and its treatment on a person’s quality of life (QOL) is not well understood.
Bonner, Ann +3 more
core +1 more source
Hydroxychloroquine Associated with Lower Glomerular Filtration Rate Decline in Lupus Nephritis
Arthritis Care &Research, Accepted Article.Background Hydroxychloroquine (HCQ) protects kidney function in lupus nephritis (LN) by preventing flares, yet some cohort studies show no significant benefit in kidney function with HCQ. Clarifying these conflicting findings by showing early and long‐term benefits of HCQ on kidney function preservation is critical. Therefore, we analyzed data from our
Shivani Garg +9 more
wiley +1 more source
Managing comorbidities in COPD
International Journal of Chronic Obstructive Pulmonary Disease, 2015 Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Age and smoking are common risk factors for COPD and other illnesses, often leading COPD patients to demonstrate multiple coexisting comorbidities. COPD exacerbations and comorbidities contribute to the overall severity in individual patients. Clinical
Ioanna Tsiligianni +3 more
openaire +6 more sources
Arthritis Care &Research, Accepted Article.Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rate for site‐specific OA across 204 countries/territories were obtained from the Global Burden of Diseases Study (GBD) 2021.
Haowei Chen +14 more
wiley +1 more source
Arthritis Care &Research, Accepted Article.Background While treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL change.
Austin Barry +16 more
wiley +1 more source